Quality of life and myelomeningocele: An ethical and evidence-based analysis of the groningen protocol

Pediatric Neurosurgery

Volumn 46, Issue 6, 2011, Pages 409-414

  Barry, Sean ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bioethics; Groningen protocol; Myelomeningocele; Neonatal euthanasia; Quality of life; Spina bifida

Indexed keywords

FOLIC ACID;

BENEFICENCE; BIOETHICS; BLADDER FUNCTION; CLINICAL PROTOCOL; DISABILITY; EUTHANASIA; EVIDENCE BASED MEDICINE; HOPELESSNESS; HUMAN; INCIDENCE; LIFE EXPECTANCY; MENINGOMYELOCELE; MULTICENTER STUDY (TOPIC); NEURAL TUBE DEFECT; NEWBORN CARE; PAIN; PARENTAL CONSENT; PHYSICAL CAPACITY; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SELF CARE; SURVIVOR; VITAMIN SUPPLEMENTATION;

EUTHANASIA, ACTIVE; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; MENINGOMYELOCELE; NETHERLANDS; PAIN; QUALITY OF LIFE;

EID: 79955393462     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000322895     Document Type: Review

References (27)

1. Verhagen E, Sauer PJ: The Groningen Protocol: Euthanasia in severely ill newborns. N Engl J Med 2005; 352: 959-962. (Pubitemid 40349495)
2. Smets T, Bilsen J, Cohen J, Rurup ML, de Keyser E, Deliens L: The medical practice of euthanasia in Belgium and The Netherlands: Legal notification, control and evaluation procedures. Health Policy 2009; 90: 181-187.
3. van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, Buiting HM, van Delden JJM, Hanssen-de Wolf JE, Janssen AG, Pasman HR, Rietjens JA, Prins CJ, Deerenberg IM, Gevers JK, van der Maas PJ, van der Wal G: End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med 2007; 356: 1957.
4. de Jong TH: Deliberate termination of life of newborns with spina bifida, a critical reappraisal. Childs Nerv Syst 2008; 24: 13-28, discussion 29-56.
5. Botto LD, Moore CA, Khoury MJ, Erickson JD: Neural-tube defects. N Engl J Med 1999; 341: 1509-1519. (Pubitemid 29526355)
6. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338: 131-137.
7. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A: Prevalence of neural tube defects in South Australia, 1966-91: Effectiveness and impact of prenatal diagnosis. BMJ 1993; 307: 703-706. (Pubitemid 23275354)
8. Aguilera S, Soothill P, Denbow M, Pople I: Prognosis of spina bifida in the era of prenatal diagnosis and termination of pregnancy. Fetal Diagn Ther 2009; 26: 68-74.
9. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA: Spina bifida outcome: A 25-year prospective. Pediatr Neurosurg 2001; 34: 114-120. (Pubitemid 32471864)
10. Barf HA, Post MW, Verhoef M, Jennekens- Schinkel A, Gooskens RH, Prevo AJ: Life satisfaction of young adults with spina bifida. Dev Med Child Neurol 2007; 49: 458-463. (Pubitemid 46845381)
11. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz-Schulman M, Lowe LH, Reed GW: Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282: 1819-1825.
12. Danzer E, Finkel RS, Rintoul NE, Bebbington MW, Schwartz ES, Zarnow DM, Adzick NS, Johnson MP: Reversal of hindbrain herniation after maternal-fetal surgery for myelomeningocele subsequently impacts on brain stem function. Neuropediatrics 2008; 39: 359-362.
13. Adzick NS: Fetal myelomeningocele: Natural history, pathophysiology, and in-utero intervention. Semin Fetal Neonatal Med 2010; 15: 9-14.
14. Lindemann H, Verkerk M: Ending the life of a newborn: The Groningen Protocol. Hastings Cent Rep 2008; 38: 42-51.
15. Kon AA: We cannot accurately predict the extent of an infant's future suffering: The Groningen Protocol is too dangerous to support. Am J Bioeth 2008; 8: 27-29.
16. Verhagen AA, Sauer PJ: End-of-life decisions in newborns: An approach from The Netherlands. Pediatrics 2005; 116: 736-739. (Pubitemid 44336693)
17. Woien S: Life, death, and harm: Staying within the boundaries of nonmaleficence. Am J Bioeth 2008; 8: 31-32.
18. Nederlandse Vereniging voor Kindergeneeskunde: Viewpoint of the Dutch Pediatric Association on 'procedure active lifeending treatment of newborns' (in Dutch). www.nvk.pedianet.nl/index.htm.
19. Jotkowitz A, Glick S, Gesundheit B: A case against justified non-voluntary active euthanasia (the Groningen Protocol). Am J Bioeth 2008; 8: 23-26.
20. Chervenak FA, McCullough LB, Arabin B: Why the Groningen Protocol should be rejected. Hastings Cent Rep 2006; 36: 30-33.
21. Verhagen AA, Sol JJ, Brouwer OF, Sauer PJ: Deliberate termination of life in newborns in The Netherlands: Review of all 22 reported cases between 1997 and 2004 (in Dutch). Ned Tijdschr Geneeskd 2005; 149: 183-188. (Pubitemid 40129163)
22. Janse AJ, Gemke RJ, Uiterwaal CS, van der Tweel I, Kimpen JL, Sinnema G: Quality of life: Patients and doctors don't always agree - a meta-analysis. J Clin Epidemiol 2004; 57: 653-661. (Pubitemid 39198951)
23. Hunt GM, Oakeshott P: Outcome in people with open spina bifida at age 35: Prospective community based cohort study. BMJ 2003; 326: 1365-1366. (Pubitemid 36751034)
24. Chervenak FA, McCullough LB, Arabin B: The Groningen Protocol: Is it necessary? Is it scientific? Is it ethical? J Perinat Med 2009; 37: 199-205.
25. Eddy DM: Evidence-based medicine: A unified approach. Health Aff (Millwood) 2005; 24: 9-17. (Pubitemid 40173932)
26. Tyson JE, Stoll BJ: Evidence-based ethics and the care and outcome of extremely premature infants. Clin Perinatol 2003; 30: 363-387. (Pubitemid 36807754)
27. Borry P, Schotsmans P, Dierickx K: Evidence- based medicine and its role in ethical decision-making. J Eval Clin Pract 2006; 12: 306-311. (Pubitemid 43806709)